Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...
Kohl’s saw sales decline in the latest quarter and now expects the full-year top line to fall 7% to 8%, creating a ...
However, while the outlook might not be great for the two companies, research firm Canalys reckons “modest” growth in the ...
The NAACP is expressing concern over how Black Americans might be affected by President-elect Trump’s Cabinet picks, some of ...
The apparel retailer reduced its guidance for the year after reporting that it swung to a loss in its fiscal third quarter on ...
Nordstrom slightly raised its annual comparable sales forecast on Tuesday owing to softness in some categories including ...
Americans’ outlook on the economy improved modestly in November, lifted by expectations for lower inflation and more hiring.
Kohl’s Corp. shares plunged to the lowest level since 2020 after the company cut its full-year sales outlook, signaling that ...